Tenderwize
Back to tender search

Open House Originale Rabattverträge 2025-23 - Rilpivirin (Film-coated tablets)

Techniker Krankenkasse·Hamburg, Germany·Deadline Sep 29, 2027 · 407 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-23 - Rilpivirin (Darreichungsform: Filmtabletten)

60/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

30 / 100

Risk factors

Contract terminates automatically upon patent expiry before end date, potentially reducing contract duration significan...

No guaranteed purchase volumes; actual uptake depends on prescription behavior.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Supply of Rilpivirin (film-coated tablets) for rebate contracts under §130c SGB V.
  • Contract max 24 months, starting 01.10.2025, ending 30.09.2027.
Show full summary

Open house procedure by Techniker Krankenkasse (with HEK and hkk as participating buyers) for rebate contracts for Rilpivirin (film-coated tablets) under §130c SGB V. All eligible pharmaceutical entrepreneurs can join at any time during the 24-month contract period (01.10.2025 - 30.09.2027). Uniform conditions, no exclusivity. Not a public procurement under EU procurement law. No estimated value provided.

Risks

Contract terminates automatically upon patent expiry before end date, potentially reducing contract duration significan...

No guaranteed purchase volumes; actual uptake depends on prescription behavior.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur under §4 Abs. 18 AMG for the offered drug.
  • Must have valid marketing authorization for Rilpivirin film tablets or be entitled to market them.

Administrative

  • Must submit self-declaration on authorization and reliability (Anlage 4).

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2025-23 - Rilpivirin (Film-coated tablets)

Rebate contracts for Rilpivirin film tablets. Open to all eligible pharmaceutical entrepreneurs.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Sep 29, 2027

Procurement Details

Publication date
22 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
482920-2025

Documents (1)

Similar tenders